질병관리청 국립보건연구원

• 1660
• Persistence of the neutralizing antibody response after SARS-CoV-2 infection
• Sang-Mu Shim
• 2022-12-23
• Clinical Microbiology and Infection
• 신종바이러스매개체연구과
• 

• 1659
• Persistence of the neutralizing antibody response after SARS-CoV-2 infection
• Sang-Mu Shim
• 2022-12-23
• Clinical Microbiology and Infection
• 신종바이러스매개체연구과
• 

• 1658
• Caudate-anchored cognitive connectivity pursuant to orthostatic hypotension in early Parkinson's disease
• Sang-Won Yoo
• 2022-12-23
• Scientific Reports
• 뇌질환연구과
• 

• 1657
• Relative infectivity of the SARS-CoV-2 Omicron variant in human alveolar cells
• Taewoo Kim
• 2022-12-22
• iScience
• 신종바이러스매개체연구과
• 

• 1656
• Complete Genome Sequence of Lacticaseibacillus rhamnosus DM065, Isolated from the Human Oral Cavity
• Do-Young Park
• 2022-12-15
• Microbiology resource announcements
• 바이오뱅크과
• 

• 1655
• Complete Genome Sequence of Hydrogen Peroxide-Producing Limosilactobacillus fermentum DM072 Isolated from the Human Oral Cavity
• Do-Young Park
• 2022-12-15
• Microbiology resource announcements
• 바이오뱅크과
• 

• 1654
• Transferability of Alzheimer Disease Polygenic Risk Score Across Populations and Its Association With Alzheimer Disease-Related Phenotypes
• Sang-Hyuk Jung
• 2022-12-15
• JAMA Network Open
• 뇌질환연구과
• 

• 1653
• Blood Krebs von den Lungen-6 levels predict treatment response to?antifbrotic therapy in?patients with?idiopathic pulmonary fbrosis
• Myeong Geun Choi
• 2022-12-09
• Respiratory Research
• 호흡기알레르기질환연구과
• 

• 1652
• Vaccination with a Zika virus envelope domain III protein induces neutralizing antibodies and partial protection against Asian genotype in immunocompetent mice
• Minna Shin
• 2022-12-05
• Tropical Medicine and International Health
• 백신연구과
• 

• 1651
• Engineered lipid nanoparticles for the treatment of pulmonary fibrosis by regulating EMT in the lungs
• Jeong Michaela
• 2022-12-03
• ADVANCED FUNCTIONAL MATERIALS
• 감염병백신연구과
•